These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7173307

  • 21. Interaction study between phenprocoumon and flurbiprofen.
    Marbet GA, Duckert F, Walter M, Six P, Airenne H.
    Curr Med Res Opin; 1977; 5(1):26-31. PubMed ID: 913120
    [Abstract] [Full Text] [Related]

  • 22. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D, Beermann D, Oesch F, Jähnchen E.
    J Pharm Pharmacol; 1980 Dec; 32(12):828-32. PubMed ID: 6110746
    [No Abstract] [Full Text] [Related]

  • 23. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W, Trenk D, Jähnchen E.
    Pharmacology; 1980 Dec; 21(5):313-22. PubMed ID: 7433511
    [Abstract] [Full Text] [Related]

  • 24. Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study.
    Ingerslev J, Mouritzen C, Stenbjerg S.
    Pharmatherapeutica; 1986 Dec; 4(9):595-600. PubMed ID: 3763653
    [Abstract] [Full Text] [Related]

  • 25. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
    Thijssen HH, Hamulyàk K.
    Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA.
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [Abstract] [Full Text] [Related]

  • 29. Cimetidine-nicoumalone interaction in man: stereochemical considerations.
    Gill TS, Hopkins KJ, Bottomley J, Gupta SK, Rowland M.
    Br J Clin Pharmacol; 1989 Apr; 27(4):469-74. PubMed ID: 2719902
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Individual variation in the response to phenprocoumon.
    Husted S, Andreasen F.
    Eur J Clin Pharmacol; 1977 Apr; 11(5):351-8. PubMed ID: 880974
    [No Abstract] [Full Text] [Related]

  • 32. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M, Korzekwa KR, Jones JP, Rettie AE, Trager WF.
    Arch Biochem Biophys; 1999 Dec 01; 372(1):16-28. PubMed ID: 10562412
    [Abstract] [Full Text] [Related]

  • 33. [Effect of BM 15075 on the blood coagulation system and on interaction with oral anticoagulants].
    Hoffrichter A, Zimmermann R, Walter E, Ehlers W, Andrassy K, Lang PD, Schlierf G, Weber E.
    Verh Dtsch Ges Inn Med; 1999 Dec 01; 83():1584-6. PubMed ID: 347788
    [No Abstract] [Full Text] [Related]

  • 34. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA, Thijssen HH, Vermeer C.
    Biochim Biophys Acta; 1986 Oct 29; 884(1):150-7. PubMed ID: 3490277
    [Abstract] [Full Text] [Related]

  • 35. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W, Jähnchen E.
    J Pharm Pharmacol; 1977 May 29; 29(5):266-71. PubMed ID: 17688
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Does oxazepam (ADUMBRAN) interfere with anticoagulant treatment. A controlled study. (author's transl)].
    Schneider J, Kamm G.
    Med Klin; 1978 Feb 03; 73(5):153-6. PubMed ID: 622064
    [Abstract] [Full Text] [Related]

  • 38. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA, Duckert F, Schönenberger PM.
    Fortschr Med; 1985 Feb 26; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract] [Full Text] [Related]

  • 39. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N, Völger R, Glogner P.
    Verh Dtsch Ges Inn Med; 1985 Feb 26; 83():1579-82. PubMed ID: 347786
    [No Abstract] [Full Text] [Related]

  • 40. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD, Toon S, Gibaldi M, Trager WF, O'Reilly RA, Goulart DA.
    Clin Pharmacol Ther; 1987 Sep 26; 42(3):312-9. PubMed ID: 3621786
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.